15
Participants
Start Date
July 31, 2007
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Octreotide LAR 30 MG Injection
Stable dose of 30 mg octreotide LAR, or a dose determined by historical dosing, delivered every 28 days for 3 months.
Cedars-Sinai Medical Center, Los Angeles
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Cedars-Sinai Medical Center
OTHER